Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index

This study aimed to validate the Clinical Treatment Score post-5 years (CTS5)-based risk stratification in a cohort comprising pre- and postmenopausal patients with estrogen receptor (ER)–positive breast cancer. We investigated the clinicopathologic parameters including Ki-67 labelling index (LI) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Janghee, Cha, Chihwan, Ahn, Sung Gwe, Kim, Dooreh, Park, Soeun, Bae, Soong June, Kim, Jeeye, Park, Hyung Seok, Park, Seho, Kim, Seung Il, Park, Byeong-Woo, Jeong, Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546620/
https://www.ncbi.nlm.nih.gov/pubmed/33033359
http://dx.doi.org/10.1038/s41598-020-74055-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546620/
https://www.ncbi.nlm.nih.gov/pubmed/33033359
http://dx.doi.org/10.1038/s41598-020-74055-3

Ejemplares similares